A new report focuses on the science and policy leading up to the US Food and Drug Administration’s (FDA) preliminary steps toward restricting industrially produced trans fatty acids, or trans fat, at the federal level. “Trans fat is a compelling topic because although it directly impacts human health, it also cues up controversy in multiple disciplines, including economics and politics,” said one expert.